CompoAtlas

Ashwagandha – Extrait de racine 500 mg

Food supplement declared in France

Ashwagandha – Extrait de racine 500 mg (TGH Lab) is a food supplement declared in France. Status: withdrawn from the market on 18 December 2025. Main ingredients: Withania somnifera 1,000 mg per day. None of the rules we check flags an issue with its declared composition.

Brand
TGH Lab
Food business operator placing the product on the market
TGH VENTURES
Status
Withdrawn from the market on 18 December 2025
Form
Capsule
Daily dose
Adultes : 2 gélules par jour, avec un verre d’eau. Ne pas dépasser la dose journalière recommandée.
Directions for use
Prendre 1 à 2 gélules par jour, de préférence au cours d’un repas ; 2 gélules par jour maximum.
Intended populations
General population, Men and women aged 18 and over
Not recommended (according to the manufacturer)
Breastfeeding women, Children (under 12), Pregnant women, Taking medication

Declaration 345249, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Withania somnifera (L.) DunalRacineExtrait sec hydroalcoolique1,000 mg

Additives

E464

Other ingredients

farine de riz

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Réservé à l’adulte. Déconseillé chez les femmes enceintes ou allaitantes. Demander l’avis d’un professionnel de santé en cas de traitement médical. Ne pas dépasser la dose journalière recommandée. À consommer dans le cadre d’une alimentation variée et équilibrée et d’un mode de vie sain. Tenir hors de portée des enfants. Conserver au frais, au sec et à l’abri de la lumière (< 25 °C).

Regulatory points

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Withania somnifera (L.) Dunal
    Read the warning, when it applies and the studies cited

    ASHWAGANDHA - WITHANIA SOMNIFERA

    Route of administration: Oral

    Cautions and warnings

    Condition of application: General debility; Memory enhancement; Adaptogen; Restlessness/nervousness.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Upton 2000; McGuffin et al. 1997).

    Sources cited by Health Canada (3)
    • McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press, LLC; 1997.
    • Upton R, editor. American Herbal Pharmacopoeia and Therapeutic Compendium: Ashwagandha Root (Withania somnifera) - Standards of Analysis, Quality Control, and Therapeutics. Santa Cruz (CA): American Herbal Pharmacopoeia; 2000.
    • Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze K, éditeurs. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13e édition. Washington (DC) : American Pharmaceutical Association; 2002.

    When using this product exercise caution if you drive or use machinery as you may experience drowsiness (Berardi et al. 2002).

    Sources cited by Health Canada (3)
    • Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA and Tietze KJ, editors. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13th edition. Washington (DC): American Pharmaceutical Association; 2002.
    • McGuffin M, Hobbs C, Upton R, Goldberg A, éditeurs. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL) : CRC Press, LLC; 1997.
    • Upton R, éditeur. Ashwagandha Root, Withania somnifera Analytical, Quality Control, And Therapeutic Monograph. Santa Cruz (CA) : American Herbal Pharmacopoeia and Therapeutic Compendium; 2000.

    Health Canada monograph dated 28 February 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Brand : TGH Lab

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Ashwagandha – Extrait de racine 500 mg (TGH Lab): composition and regulation”, https://compoatlas.com/en/supplements/products/345249-ashwagandha-extrait-de-racine-500-mg, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line